Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R F Dielschneider
Gefitinib Targets ZAP-70-expressing Chronic Lymphocytic Leukemia Cells and Inhibits B-Cell Receptor Signaling
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Metformin Inhibits Cell Cycle Progression of B-Cell Chronic Lymphocytic Leukemia Cells
Oncotarget
Oncology
The Outcome of B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia: Proliferation or Anergy
Haematologica
Hematology
Constitutive Activation of the B Cell Receptor Underlies Dysfunctional Signaling in Chronic Lymphocytic Leukemia
Cell Reports
Biochemistry
Genetics
Molecular Biology
CXCL12-induced Chemotaxis Is Impaired in T Cells From Patients With ZAP-70-negative Chronic Lymphocytic Leukemia
Haematologica
Hematology
Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukaemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Interdomain B in ZAP-70 Regulates but Is Not Required for ZAP-70 Signaling Function in Lymphocytes
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia
Annals of Hematology
Medicine
Hematology
B-Cell Receptor Translocation to Lipid Rafts and Associated Signaling Differ Between Prognostically Important Subgroups of Chronic Lymphocytic Leukemia
Cancer Research
Cancer Research
Oncology